Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
480 Leser
Artikel bewerten:
(2)

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World's First Fully Robotic Living Donor Liver Transplant

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) -- In a historic achievement, the Organ Transplant Center of Excellence (OTCoE) team at King Faisal Specialist Hospital & Research Centre (KFSH&RC) has successfully performed the world's first fully robotic living donor liver transplant in the Kingdom of Saudi Arabia-a move that solidifies KFSH&RC's position as a global leader in minimally invasive transplant surgery.

KFSH&RC's pioneering approach employed state-of-the-art robotic technology to conduct both donor and recipient surgeries with precision and minimal invasiveness, eliminating the need for a hybrid approach. While other centres offer minimally invasive liver transplants using mixed techniques, KFSH&RC is the only centre to complete a fully robotic living donor liver transplant surgery successfully.

This accomplishment represents a significant leap forward in the history of transplantation, a testament to the centre's commitment to advanced practices that enhance healthcare outcomes, improve the patient experience, and boost hospital operational efficiency. It has also led to a reduction in the risk of complications, recovery time, and the length of hospital stays.

As a strategic health partner at the Global Health Exhibition held in Riyadh from October 29 to October 31, KFSH&RC is showcasing its latest innovations at the forum. Attendees will gain insights into the OTCoE's expertise in applying cutting-edge technologies to expand healthcare possibilities.

KFSH&RC has set records in successfully conducting reciprocal kidney transplants, a medical approach that facilitates kidney transplants between two donors from different families simultaneously. In 2022, the program achieved a remarkable milestone by completing 91 reciprocal transplants, surpassing its international counterparts.

KFSH&RC's OTCoE is a pioneer in the Kingdom, representing one of the most advanced and comprehensive facilities for multi-organ transplantation in the Middle East. Its services encompass kidney, liver, lung, pancreas, and intestine transplants, collectively called solid organ transplantation.

KFSH&RC is globally renowned for its exceptional contributions to specialized healthcare, commitment to innovation, and dedication to advanced medical research and education. Furthermore, KFSH&RC is steadfast in its pursuit of developing medical technologies and elevating the standard of healthcare globally by collaborating with major local, regional, and international institutions. It is committed to delivering world-class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/888a9b0a-3cd2-4186-ab5e-b44eb8f0d9cb

https://www.globenewswire.com/NewsRoom/AttachmentNg/250c97ba-0d78-4a24-83a5-73e063b3366b



KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.